1. Home
  2. ANVS vs STCN Comparison

ANVS vs STCN Comparison

Compare ANVS & STCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANVS
  • STCN
  • Stock Information
  • Founded
  • ANVS 2008
  • STCN 1986
  • Country
  • ANVS United States
  • STCN United States
  • Employees
  • ANVS N/A
  • STCN N/A
  • Industry
  • ANVS Biotechnology: Pharmaceutical Preparations
  • STCN Advertising
  • Sector
  • ANVS Health Care
  • STCN Consumer Discretionary
  • Exchange
  • ANVS Nasdaq
  • STCN Nasdaq
  • Market Cap
  • ANVS 110.4M
  • STCN 63.4M
  • IPO Year
  • ANVS 2020
  • STCN 1994
  • Fundamental
  • Price
  • ANVS $9.57
  • STCN $10.40
  • Analyst Decision
  • ANVS Strong Buy
  • STCN
  • Analyst Count
  • ANVS 6
  • STCN 0
  • Target Price
  • ANVS $29.67
  • STCN N/A
  • AVG Volume (30 Days)
  • ANVS 341.4K
  • STCN 11.9K
  • Earning Date
  • ANVS 11-06-2024
  • STCN 12-12-2024
  • Dividend Yield
  • ANVS N/A
  • STCN N/A
  • EPS Growth
  • ANVS N/A
  • STCN 203.29
  • EPS
  • ANVS N/A
  • STCN 3.17
  • Revenue
  • ANVS N/A
  • STCN $169,044,000.00
  • Revenue This Year
  • ANVS N/A
  • STCN N/A
  • Revenue Next Year
  • ANVS N/A
  • STCN N/A
  • P/E Ratio
  • ANVS N/A
  • STCN $3.19
  • Revenue Growth
  • ANVS N/A
  • STCN N/A
  • 52 Week Low
  • ANVS $4.53
  • STCN $7.36
  • 52 Week High
  • ANVS $22.49
  • STCN $13.00
  • Technical
  • Relative Strength Index (RSI)
  • ANVS 58.70
  • STCN 57.19
  • Support Level
  • ANVS $9.00
  • STCN $9.90
  • Resistance Level
  • ANVS $10.54
  • STCN $10.29
  • Average True Range (ATR)
  • ANVS 0.81
  • STCN 0.39
  • MACD
  • ANVS 0.12
  • STCN 0.11
  • Stochastic Oscillator
  • ANVS 74.57
  • STCN 100.00

About ANVS Annovis Bio Inc.

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.

About STCN Steel Connect Inc.

Steel Connect Inc is a diversified holding company. The company's operating segment include Direct Marketing and Supply Chain. It generates maximum revenue from the Direct Marketing segment. Geographically, it derives a majority of revenue from the United States and also has a presence in China; Netherlands, and others. The company serves clients in various industries including consumer electronics, communications, computing, software, storage, and retail industries.

Share on Social Networks: